Dan A. Wiginton - Publications

Affiliations: 
University of Cincinnati, Cincinnati, OH 
Area:
Molecular Biology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Dusing MR, Maier EA, Aronow BJ, Wiginton DA. Onecut-2 knockout mice fail to thrive during early postnatal period and have altered patterns of gene expression in small intestine. Physiological Genomics. 42: 115-25. PMID 20354101 DOI: 10.1152/Physiolgenomics.00017.2010  0.387
2006 Maier EA, Dusing MR, Wiginton DA. Temporal regulation of enhancer function in intestinal epithelium: a role for Onecut factors. The Journal of Biological Chemistry. 281: 32263-71. PMID 16950765 DOI: 10.1074/Jbc.M606699200  0.452
2005 Maier EA, Dusing MR, Wiginton DA. Cdx binding determines the timing of enhancer activation in postnatal duodenum. The Journal of Biological Chemistry. 280: 13195-202. PMID 15677472 DOI: 10.1074/Jbc.M413158200  0.383
2003 Dusing MR, Florence EA, Wiginton DA. High-level activation by a duodenum-specific enhancer requires functional GATA binding sites. American Journal of Physiology. Gastrointestinal and Liver Physiology. 284: G1053-65. PMID 12571085 DOI: 10.1152/Ajpgi.00483.2002  0.463
2002 Bates MD, Erwin CR, Sanford LP, Wiginton D, Bezerra JA, Schatzman LC, Jegga AG, Ley-Ebert C, Williams SS, Steinbrecher KA, Warner BW, Cohen MB, Aronow BJ. Novel genes and functional relationships in the adult mouse gastrointestinal tract identified by microarray analysis. Gastroenterology. 122: 1467-82. PMID 11984531 DOI: 10.1053/Gast.2002.32975  0.387
2001 Dusing MR, Florence EA, Wiginton DA. Pdx-1 is required for activation in vivo from a duodenum-specific enhancer. Journal of Biological Chemistry. 276: 14434-14442. PMID 11278481 DOI: 10.1074/Jbc.M009249200  0.469
2000 Dusing MR, Brickner AG, Lowe SY, Cohen MB, Wiginton DA. A duodenum-specific enhancer regulates expression along three axes in the small intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 279. PMID 11053006 DOI: 10.1152/Ajpgi.2000.279.5.G1080  0.411
1999 Brickner AG, Koop BF, Aronow BJ, Wiginton DA. Genomic sequence comparison of the human and mouse adenosine deaminase gene regions Mammalian Genome. 10: 95-101. PMID 9922386 DOI: 10.1007/S003359900951  0.466
1997 Dusing MR, Brickner AG, Thomas MB, Wiginton DA. Regulation of Duodenal Specific Expression of the Human Adenosine Deaminase Gene Journal of Biological Chemistry. 272: 26634-26642. PMID 9334245 DOI: 10.1074/Jbc.272.42.26634  0.463
1995 Brickner AG, Gossage DL, Dusing MR, Wiginton DA. Identification of a murine homolog of the human adenosine deaminase thymic enhancer. Gene. 167: 261-266. PMID 8566789 DOI: 10.1016/0378-1119(95)00673-7  0.44
1995 Aronow BJ, Ebert CA, Valerius MT, Potter SS, Wiginton DA, Witte DP, Hutton JJ. Dissecting a locus control region: facilitation of enhancer function by extended enhancer-flanking sequences. Molecular and Cellular Biology. 15: 1123-1135. PMID 7823928 DOI: 10.1128/Mcb.15.2.1123  0.456
1994 Dusing MR, Wiginton DA. Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter Nucleic Acids Research. 22: 669-677. PMID 8127716 DOI: 10.1093/Nar/22.4.669  0.434
1992 Aronow BJ, Silbiger RN, Dusing MR, Stock JL, Yager KL, Potter SS, Hutton JJ, Wiginton DA. Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Molecular and Cellular Biology. 12: 4170-4185. PMID 1508212 DOI: 10.1128/Mcb.12.9.4170  0.489
1991 Witte DP, Wiginton DA, Hutton JJ, Aronow BJ. Coordinate developmental regulation of purine catabolic enzyme expression in gastrointestinal and postimplantation reproductive tracts Journal of Cell Biology. 115: 179-190. PMID 1918135 DOI: 10.1083/Jcb.115.1.179  0.368
1991 Wiginton D, Aronow B, Silbiger R, Potter S, Hutton J. Regulation of the human adenosine deaminase gene by first intron sequences: a T-cell enhancer. Advances in Experimental Medicine and Biology. 57-60. PMID 1781406 DOI: 10.1007/978-1-4615-7703-4_13  0.503
1991 Aronow B, Witte D, Wiginton D, Hutton J. Highest ADA expressing mouse tissues also exhibit cell-type specific coordinate up-regulation of purine degradative enzymes. Advances in Experimental Medicine and Biology. 229-33. PMID 1781373 DOI: 10.1007/978-1-4615-7703-4_51  0.414
1989 Akeson AL, Wiginton DA, Hutton JJ. Normal and mutant human adenosine deaminase genes. Journal of Cellular Biochemistry. 39: 217-28. PMID 2651461 DOI: 10.1002/Jcb.240390302  0.455
1988 Markert ML, Hutton JJ, Wiginton DA, States JC, Kaufman RE. Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements. The Journal of Clinical Investigation. 81: 1323-7. PMID 3366897 DOI: 10.1172/Jci113458  0.455
1987 Akeson AL, Wiginton DA, States JC, Perme CM, Dusing MR, Hutton JJ. Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing. Proceedings of the National Academy of Sciences of the United States of America. 84: 5947-51. PMID 3475710 DOI: 10.1073/Pnas.84.16.5947  0.41
1987 Wiginton DA, Kaplan DJ, States JC, Akeson AL, Perme CM, Bilyk IJ, Vaughn AJ, Lattier DL, Hutton JJ. Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry. 25: 8234-44. PMID 3028473 DOI: 10.1021/Bi00373A017  0.428
1986 Kantoff PW, Kohn DB, Mitsuya H, Armentano D, Sieberg M, Zwiebel JA, Eglitis MA, McLachlin JR, Wiginton DA, Hutton JJ. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proceedings of the National Academy of Sciences of the United States of America. 83: 6563-6567. PMID 3489233 DOI: 10.1073/Pnas.83.17.6563  0.41
1985 Hutton JJ, Wiginton DA. Molecular Biology of the Adenosine Deaminase Gene and Messenger RNAa Annals of the New York Academy of Sciences. 451: 227-237. PMID 3865573 DOI: 10.1111/J.1749-6632.1985.Tb27113.X  0.412
1984 Adrian GS, Wiginton DA, Hutton JJ. Characterization of normal and mutant adenosine deaminase messenger RNAs by translation and hybridization to a cDNA probe Human Genetics. 68: 169-172. PMID 6548726 DOI: 10.1007/Bf00279309  0.378
1984 Wiginton DA, Adrian GS, Hutton JJ. Sequence of human adenosine deaminase cDNA including the coding region and a small intron. Nucleic Acids Research. 12: 2439-2446. PMID 6546794 DOI: 10.1093/Nar/12.5.2439  0.363
1984 Adrian GS, Wiginton DA, Hutton JJ. Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines. Molecular and Cellular Biology. 4: 1712-1717. PMID 6208479 DOI: 10.1128/Mcb.4.9.1712  0.412
1983 Wiginton DA, Adrian GS, Friedman RL, Suttle DP, Hutton JJ. Cloning of cDNA sequences of human adenosine deaminase. Proceedings of the National Academy of Sciences of the United States of America. 80: 7481-5. PMID 6200875 DOI: 10.1073/Pnas.80.24.7481  0.446
1981 Hutton JJ, Wiginton DA, Coleman MS, Fuller SA, Limouze S, Lampkin BC. Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy. The Journal of Clinical Investigation. 68: 413-21. PMID 7263861 DOI: 10.1172/Jci110270  0.304
Show low-probability matches.